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BACKGROUND: Induction of labor using oxytocin is a routine procedure in obstetrics used for vaginal 
delivery of gravid uterus. The purpose of this study was to analyze outcome of induction with oxytocin 
and associated factors among mothers who delivered at term and post-term in Jimma University 
Specialized Hospital, Southwest Ethiopia. 
METHODS: A facility based cross-sectional study was conducted on records of 280 laboring mothers 
who delivered at term and post-term after induction with oxytocin from September 1
st
, 2009 to August 
31
st
, 2011.  The data were extracted using checklist and analyzed using SPSS windows version 16.0. The 
level of significance to declare relationship between the dependent and independent variables was set at 
p< 0.05. 
RESULTS: Mean maximum oxytocin levels used until vaginal delivery and at time of diagnosis of failed 
induction were 55.0 ± 29.8 and 89.7± 11.6 miu/min respectively. Mean time elapsed from initiation of 
induction with oxytocin to vaginal delivery and till diagnosis of failed induction were 6:10 ± 3:09 and 
9:57± 2:01 hours respectively. Failed induction was diagnosed in 21.4% of the mothers. Primigravidity, 
unfavorable and intermediate Bishop Scores determined at admission were found to be predictors of 
failed induction.  
CONCLUSION: High rate of failed induction and high level of oxytocin use were found.  Preparation of 
the cervix before commencing induction in primigravid women is recommended to improve success of 
induction with the current protocol.  






Induction of labor refers to the iatrogenic 
stimulation of uterine contractions before the onset 
of spontaneous labor with or without ruptured 
membranes to accomplish vaginal delivery. 
Generally, induction of labor has merit as a 
therapeutic option when the benefits of 
expeditious delivery outweigh the risks of 
continuing the pregnancy (1-3). 
The rate of labor induction varies by location 
and institution, and is increasing. In the United 
States and Canada, it is greater than 20% (1, 4, & 
5). Although induction of labor with oxytocin is a 
daily practice at public and private health 
institutions, there is only one published study done 
in Ethiopia in 2004. According to this two years’ 
retrospective case-series from two teaching 
hospitals in Addis Ababa, the prevalence of 
induction at term and post-term was 4% in both 
institutions (6). 
Indications for induction of labor are not 
absolute but should take into account maternal and 
fetal conditions, gestational age, cervical status 
and other factors. Some of the maternal or fetal 
conditions that may be indications for 
induction of labor are abruptio placentae, 
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chorioamnionitis, fetal demise, pregnancy-induced 
hypertension, premature rupture of membranes 
(PROM), post-term pregnancy, maternal medical 
conditions (e.g., diabetes mellitus, renal disease, 
chronic pulmonary disease, chronic hypertension), 
fetal compromise (e.g., severe fetal growth 
restriction, iso-immunization), preeclampsia, and 
eclampsia. Labor may also be induced for logistic 
reasons like risk of precipitated labor, distance 
from hospital, or psychosocial indications (1-4). 
Induction of labor should be used only when 
the benefits to the fetus or the mother of the baby 
outweigh those of the pregnancy continuing. The 
major risks associated with induction of labor 
include: increased cesarean delivery [C/D] (more 
on nulliparas) and operative vaginal delivery rate, 
chorioamnionitis, tachysystole with abnormal fetal 
heart rate patterns, uterine atony, increased cost, 
and rarely uterine rupture (1-4, 5). 
Uterine activity and electronic fetal 
monitoring (EFM) are recommended for any 
gravida receiving uterotonic drugs (1-3). No 
consensus has been reached regarding the 
diagnosis of failed induction. A variety of end 
points have been suggested including cesarean 
delivery, not achieving a vaginal delivery within a 
specified time (such as within 12 or 24hs), not 
achieving active labor within a specified time, or 
failure to achieve the active phase of labor (5). 
The definition of failed induction should be 
derived from what is known about the pattern of 
labor progression in women undergoing induced 
labor who ultimately achieve vaginal delivery 
while maintaining a low incidence of adverse 
maternal and neonatal outcomes. The goal is to 
minimize the number of cesarean deliveries 
performed for failed induction in patients who are 
progressing slowly because they are still in the 
latent phase of labor. Once induced women enter 
active labor, progression should be comparable to 
progression in women with spontaneous active 
labor, or faster (4, 7).  
       Because of the risk of failed induction of 
labor, a variety of maternal and fetal factors as 
well as screening tests have been suggested to 
predict labor induction success. These include 
maternal factors [such as parity, height, weight, 
body mass index (BMI), maternal age, Bishop 
Score and its individual components], fetal factors 
(such as birth weight and gestational age), 
transvaginal ultrasound (TVUS) assessment of the 
cervix, and biochemical markers [including fetal 
fibronectin (fFN) and insulin-like growth factor 
binding protein-1 (IGFBP-1)] (1-3, 5 & 8).The 
exact pharmacological half-life of oxytocin is 
controversial, but the available data suggest that a 
stable uterine response is obtained in 40 - 60 
minutes after initiating a constant-dose infusion. 
Therefore, the physiological half-life may be close 
to 10 minutes, since approximately four ‘half-
lives’ are required to obtain constant plasma levels 
(9). 
Oxytocin protocols can be divided into two 
broad categories: high dose and low dose. This 
classification depends on the initial oxytocin dose, 
the amount of sequential increase in oxytocin 
dose, and the rate at which the dose is increased. 
Concerns about the safety and efficacy of the 
high-dose and low-dose protocols form the 
cornerstone of the debate regarding which 
protocol should be used in clinical practice (1-3). 
Low dose protocols mimic endogenous 
maternal physiology and are associated with lower 
rates of uterine hyperstimulation. Low dose 
oxytocin is initiated at 0.5 to 1miu and increased 
by 1 miu/min at 40- to 60-minutes interval. 
Slightly higher doses beginning at 1 to 2miu/min 
increased by 1 to 2miu/min, with shorter 
incremental time intervals of 15 to 30 minutes 
have also been recommended. High dose oxytocin 
regimens are often employed in active 
management of labor protocols. These regimens 
are largely used for labor augmentation, rather 
than for labor induction. Examples of these 
protocols start with an initial oxytocin dose of 
6miu/min increased by 6miu/min at 20 minute 
intervals or start at 4miu/min with 4miu/min 
incremental increases (1-3). Although most 
protocols do not exceed 42miu/min, arbitrary 
maximum doses of oxytocin in various protocols 
have ranged from 20 to 40miu/min. Some 
practitioners have felt that a maximum dose is 
truly arbitrary and that the oxytocin should be 
administered until an adequate end-organ (uterine 
contraction) response is obtained (1, 3, & 10).  
Despite the controversies surrounding the use 
of induction with oxytocin to initiate labor and the 
absence of technological supports to evaluate 
likelihood of success in resource limited settings, 
there are few empirical evidences in relation to 
outcome of induction in Ethiopian hospitals. Thus, 
in this study, we aimed to answer the following 
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two questions: What is the rate of failed induction 
among term and post-term women giving birth at 
Jimma University Specialized Hospital (JUSH)? 
What factors predict the outcome of induction in 
this group of mothers?  
 
METHODS AND MATERIALS 
The study was conducted in JUSH found in Jimma 
town (352 km southwest of Addis Ababa). It is the 
only teaching and referral hospital in the 
southwestern part of the country. The hospital has 
a bed capacity of 450 of which 52 beds belong to 
the obstetric ward. The department gives 24 hours 
service of attending normal and abnormal labor 
including emergency cesarean section and 
laparotomy. During the study period, there were 
seven consultant gynecologists, 20 residents of 
four groups starting from 1
st
 year to 4
th
 year, 
varying numbers of medical interns, six midwives, 
and 20 clinical nurses. The hospital has a total of 
more than 750 staff (supportive and technical). It 
provides services for approximately 9000 inpatient 
and 80,000 outpatient attendances coming to the 
hospital from the catchment population of about 
15,000,000 a year. 
A cross-sectional study was conducted by 
reviewing records of term and post-term deliveries 
from  September 1
st
 , 2009 to  August 31
st
 , 2011. 
Hence, the source population was comprised of 
women who were admitted at term and post-term 
to the maternity and labor wards of the hospital 
during the study period. The study population 
included all women with term and post-term 
pregnancy who were admitted to the maternity and 
labor wards of the hospital and had induction with 
oxytocin during the study period.  
Data were collected through review of 
medical records using a checklist which was 
prepared after reviewing different relevant 
literatures (6, 8, 11, 12 & 13). Patient cards, labor 
ward log books, discharge log books, operation 
room log books, and medical interns’ reporting log 
books were reviewed to collect the required data.  
Data were collected by 10 trained medical interns 
and two first year residents under supervision of 
the principal investigator. All collected data were 
reviewed by the principal investigator for their 
completeness on daily basis. 
    Data were cleaned and entered into computer 
software to be analyzed using SPSS version 16.0. 
Results were presented using tables where 
frequencies, percentages and mean ± SD were 
used whenever appropriate. Normally distributed 
continuous variables were compared using 
independent t-test. Bivariate analysis was carried 
out to determine associations of selected variables 
with the dependent variable and p-value of less 
than or equal to 0.25 was taken as a cut-off point 
to select candidate variables for the final multiple 
logistic regression models. Independent predictors 
were determined using adjusted odds ratio with 
95% confidence interval in multiple regression 
analysis at p-value < 0.05.  
   Prior to data collection, ethical clearance was 
obtained from Ethical Clearance Committee of the 
College of Public Health and Medical Sciences of 
Jimma University. Additionally, confidentiality of 
patient information was ensured by omitting their 
names and using card numbers instead. 
   In this study, outcome of induction was 
defined as successful if  a woman delivered 
vaginally either spontaneously or by an instrument 
after induction with oxytocin. Failed if a woman 
delivered by C/S due to failure to acquire either 
adequate uterine contraction (≥3 contractions or 
contractions lasting ≥40 seconds in ten minutes 
period) or failed to show favorable cervical 
changes (reach at least 4cm  in dilatation and fully 
effaced) despite being on oxytocin drip for at least 
six hours or diagnosed as failed induction by the 
treating resident. 
Table on labor induction protocol with oxytocin 
for all pregnant women in JUSH, using 6 units of 
oxytocin in 1000ml of IV fluids, start at 6 mu/min, 














Table 1: Protocol of induction of labor with oxytocin for all gravid women of JUSH  
 








Net IV fluid loss = 220ml  
Net oxytocin loss=1200mu  
Oxytocin to be added in same bag =6units  
Current concentration =13.5mu/ml  
2
nd
 40 27 
60 40.5 
80 54 
Net IV fluid loss =180ml  
Net oxytocin loss =2430mu  
Oxytocin to be added in same bag =6units  
Current concentration =23.2mu/ml  
3
rd
  60 69.5 
80 92.7 







1000ml of IV fluid is over, 18units of oxytocin added to 1000ml of 






N.B. Interval between each dose is 20 minutes. 
 
RESULTS  
Of the total 354 records of mothers who delivered 
at term and post-term after being induced with 
oxytocin drip during the study period, 314 charts 
were retrieved making chart retrieval rate of 
88.7%. Fourteen charts were excluded from the 
analysis because of immediate development of 
non-reassuring fetal heart rate pattern (NRFHR) 
after initiation of oxytocin, 20 charts were also 
excluded from the study because of 
incompleteness. Analysis was based on the 
remaining 280 charts. 
The age of the study subjects ranged from 18-
39 years and their mean age was 25.9 (SD=4.2) 
years. Of these, 175(62.5%) had term pregnancy, 
and multigravida mothers made up 152(54.3%) of 
the study subjects. One hundred twenty (45.4%) of 
the women had unfavorable Bishop Score at 
admission. Usage of vaginal misoprostol of 25 
microgram (mcg) for cervical ripening before 
initiation of induction with oxytocin was 
documented in 80(61.5%) of the women. The top 
three indications for induction in this study were 
PROM (36.6%), hypertensive disorders of 
pregnancy (34.3%) and post-term pregnancy 
(23.2%). One hundred and eighty-two (65.0%) 
mothers underwent induction of labor on 
emergency basis (Table 2). 
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 Table 2: Characteristics of pregnant mothers who underwent oxytocin induction in JUSH from September 
1
st




Variables  No. (%) 
Age in years (N= 280)  
 
 






Gestational Age (N= 280) Term 175(62.5) 
Post-term 105(37.5) 
Gravidity (N= 280) Gravida I 128(45.7) 
Gravida II 78(27.9) 
Gravida III 42(15.0) 
Gravida IV 12(4.3) 
Gravida V & above 20(7.1) 
Timing of induction (N= 280) Planned 98(35.0) 
Emergency 182(65.0) 
Indication for induction (N= 280) PROM 102(36.4) 
Hypertension 96(34.3) 
Post-term 65(23.2) 
No reason 17(6.1) 






Usage of 25 mcg of vaginal misoprostol to ripen 




Outcome of induction with oxytocin: Of the 280 
women, 154(55%) had spontaneous vertex 
delivery, 96(34.2%) underwent cesarean section 
and 30(10.7%) had instrumental delivery. 
Induction was successful in 184(65.7%) of the 
study subjects, while 60(21.4%) of the mothers 
experienced failed induction. Nineteen (6.8%) 
neonates were low birth weight (< 2500 gram) and 
248 (88.6%) had normal birth weight (2500- 3999 












Table 3: Outcome of induction with oxytocin of pregnant mothers in JUSH from September 1
st
, 2009 to 
August 31
st
, 2011  
Variable  No. (%)  
Route of delivery (N= 280) Spontaneous vertex delivery 154(55.0) 
Instrumental delivery 30(10.7) 
C/S for NRFHR pattern 25(8.9) 
C/S for CPD 7(2.5) 
C/S for failed instrument 4(1.4) 
C/S for failed induction 60(21.4) 
Neonatal weight (gram) (N= 280) Mean ± SD 3139.86±496.013 
Range  2000 – 5000 
<2500 19(6.8) 
2500-2999 80(28.6) 
3000- 3499 106(37.9) 
3500- 3999 62(22.1) 
≥4000 13(4.6) 
 
Mean doses of oxytocin maintained in miu/min for 
those with successful and failed inductions were 
55.0 ± 29.8 & 89.7 ± 11.6, respectively. Range of 
level of oxytocin used varied from 6.0 to 93.0 and 
48.0 to 95.0 miu/min for women with successful  
 
and failed inductions, respectively. Mean time 
elapsed from the start of induction with oxytocin 
to delivery in hours for cases with successful 
induction was 6.10 ± 3.09 hours, while it was as 
high as 9.57 ± 2.01 hours for those who had failed 
induction (Table 4). 
 
Table 4: Dose of oxytocin maintained and time elapsed till delivery in JUSH from September 1
st
, 2009 to 
August 31
st
, 2011  
 
  Variable  Frequency   
Successful induction Failed induction 
Dose of oxytocin maintained (miu/min) 
Mean ± SD 55.0 ± 29.8 89.7 ± 11.6 
Median  54.0 93.0 
Minimum  6.0 48.0 
Maximum  93.0 95.0 
Range   87.0  47.0 
Time from start to delivery (hours) Mean ± SD 6.10 ± 3.09 9.57 ± 2.01 
Median  5.15 9.00 
Minimum  1.40 6.00 
Maximum  16.00 14.00 
Range  14.60 8.00 
 
Predictors of outcome of induction: Different 
socio-demographic and obstetric variables were 
entered in stepwise regression. In the initial 
model, mean age, gravidity, Bishop Score, timing 
of induction and neonatal weight demonstrated 
statistically significant association with the 
outcome variable at p <0.25. However, only 
gravidity of the women and Bishop Score at 
admission persisted as independent predictors of 
outcome of induction with oxytocin in the 
multivariate model. Hence, primigravid women 
were 2.3 times more likely to have failed 
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induction as compared to multigravid mothers 
(AOR = 2.298, 95 % CI. 1.109,4.763). Those 
women who had unfavorable Bishop Score at 
admission were 5.3 times more likely to have 
failed induction as compared to those women with 
favorable Bishop score (AOR= 5.275, 95 % CI. 
2.005,13.878). Moreover, those women with 
intermediate Bishop Score at admission were 4.3 
times more likely to have failed induction 
compared to those women with favorable Bishop 
Score at admission (AOR= 4.287, 95 % CI. 
1.432,12.834) (Table 5). 
 
Table 5: Predictors of failed induction among pregnant mothers who underwent induction with oxytocin in JUSH from 
September 1
st
 2009 to August 31
st
 2011.  
Variable  Successful 
(N= 184) 
Failed (N= 60) Crude OR 
(95% CI) 
Adjusted OR (95% 
CI) 
Age    1.042(0.975, 1.114) 1.077 (0.990, 1.172) 
≤ 20 22(84.6%) 4(15.4%) 1* 1* 
21- 25 76(71%) 31(29%) 2.243(0.714, 7.045) 1.931(0.565,6.605) 
26- 30 68 (81.9%) 15(18.1%) 1.213 (0.364, 4.041) 1.237(0.330,4.644) 
31- 35 14 (63.6%) 8 (36.4%) 3.143 (0.795, 12.425) 3.541(0.732,17.122) 
≥ 36 4 (66.7%) 2 (33.3%) 2.750 (0.371, 20.402) 6.238(0.665,58.468) 
Gestational age  
Term  119 (78.3%) 33(21.7%) 1.498(0.829, 2.707) 1.408(0.551,3.596) 
Post term 65 (70.7%) 27(29.3%) 1* 1* 
Timing of induction  
Planned   62 (72.1%) 24 (27.9%) 1* 1* 
Emergency 122 (77.2%) 36 (22.8%) 0.762(0.418, 1.389) 0.802(0.316,2.032) 
Gravidity   
Primigravida 75(67.0%) 37(33.0%) 2.338 (1.286, 4.250) 2.298(1.109,4.763) † 
Multigravida 109(82.6%) 23(17.4%) 1* 1* 
PROM  
Yes 69 (80.2%) 17 (19.8%) 1* 1* 
No 115 (72.8%) 43 (27.2%) 1.518(0.804, 2.866) 0.787(0.338,1.830) 
Bishop Score status 
at time of admission  
 
Unfavorable  70 (64.8%) 38 (35.2%) 6.243(2.481, 15.712) 5.275(2.005,13.878) † 
Intermediate   45(73.8%) 16(26.2%) 4.089(1.488, 11.234) 4.287(1.432,12.834) † 
Favorable   69(92.0%) 6(8.0%) 1* 1* 







Weight of neonates 
(gm) 
 
< 3000 73 (78.5%) 20(21.5%) 1* 1* 
3000- 3499 75 (78.1%) 21 (21.9%) 1.02(0.512, 2.042) 1.216(0.520,2.845) 
3500- 3999 27(62.8%) 16 (37.2%) 2.163(0.980,4.775) 2.379(0.942,6.009) 
≥4000  9 (75%) 3(25%) 1.217(0.301,4.920) 2.136(0.407,11.212) 
N.B.  1* - reference, † statistically significant at P- Value ≤ 0.05 
DISCUSSION  
The rate of failed induction was high at 21.4%. 
Primigravidity and having admission time Bishop 
Scores of unfavorable and intermediate were 
found to be independent predictors of failed 
induction.  
The rate of failed induction in this study is 
comparable to the rate in the study done in Addis 
Ababa (28.4%) (6). This is due to the similarity in 
the definition of failed induction time which is six 
to eight hours in both protocols which is not 
explained by their differences in the dose and 
escalation time interval used. It is also comparable 
to the failed induction rate of a study in Nigeria 
(18%) (16). The failure rate is found to be higher 
than the rates of failed inductions of many other 
studies elsewhere: 15.2% in Australia (15), 4% of 





nulliparas in Birmingham (17), 2% in Illinois (18), 
6% in Iowa  (12). 
Reasons for this high rate of failure in our set 
up could be due to failure in maintaining the 
serum oxytocin concentration during change of 
infusion bag while the infusing bag is completed. 
Inappropriate storage of oxytocin which the 
principal investigator has witnessed himself 
during his practice as a resident can also be an 
other reason. Another explanation is the dose 
increment interval being every 20 minutes which 
is not in accordance with the currently accepted 
oxytocin pharmacokinetics which states a 
minimum of forty minutes is required to achieve 
steady serum level (9 & 14).  
Another possible reason for the high rate of 
failure could be the limited time that is used to 
define failed induction (6 to 8 hours). Compared 
to the Birmingham  study, a minimum of 12 to 18 
hours of membrane rupture and oxytocin 
administration before declaring failed induction is 
necessary (17). 
Compared to the study done in Illinois, USA, 
a latent phase of as long as 18 hours during 
induction of labor in nulliparous women allows 
the majority of these women to achieve a vaginal 
delivery without being subject to a significantly 
increased risk of significant maternal or neonatal 
morbidity (18) The Australian study concluded 
that it would seem reasonable to continue an 
oxytocin infusion for at least ten hours in women 
undergoing induction who have yet to reach the 
active phase of labor (≥ 4 cm), and unclear benefit 
in continuing an induction beyond 12 h (15). 
Primigravidity as an independent predictor 
for failed induction was also seen in most of the 
studies reviewed (1- 3, 5, 13, 19). Admission time 
unfavorable Bishop Score and intermediate 
Bishop Score were shown to be predictors of 
failed induction in most of the studies reviewed 
(1-3, 5, 8, 13, 20, 21, 22).  
Mean oxytocin level maintained (55.0 ± 29.8 
miu/min) for those women with successful 
induction was higher than the mean dose of 
oxytocin used to attain adequate uterine 
contraction in Addis Ababa’s study which is  (33.6 
± 21.9 miu/min in primiparas and 17.2 ±11.4 
miu/min in multiparas  (6). This is due to the 
slight difference in the protocols used at these 
institutions: our protocol allows a maximum 
oxytocin dose of 95miu/ml, while the maximum 
dose attainable in Addis study is 73.4miu/min for 
primigravidas. Of note, large doses of oxytocin 
were administered in the high-dose induction 
(range=4.5 to 117 mIU/min) in the Iowa study 
(12).  
It was also higher than the study done in 
Thomas Jefferson University, which suggested 
maximum dose of 16 mIU/min. This is due to the 
protocol difference from this study; in the Thomas 
Jefferson University, a starting dose of 2 mIU/min 
with dilution of 10mIU/mL, increase by 2 
mIU/min every 45 minutes was used (14). 
Mean dose of oxytocin maintained for those 
women with failed induction (89.7±11.6 miu/min) 
with a range of 48.0-95.0 miu/min was higher than 
mean maximum level at diagnosis of failed 
induction (60±16.2`miu/min for primiparous) used 
in the Addis’ study (6). This can also be due to the 
difference in protocol. 
Mean time elapsed from initiation of oxytocin 
to vaginal delivery (6:10 ± 3:09 hours), with a 
range of 1:40-16:00 hours was comparable to the 
Addis’ induction initiation to vaginal delivery time 
(7:10 ± 3:25 hours) (6). This can be explained by 
the fact that once women attain adequate uterine 
contraction, they follow the natural course of 
progress in active first stage of labor despite time 
interval.  
       This time is also comparable to the study done 
in Iowa, USA, which showed that with the high 
dose regimen, mean time from initiation to vaginal 
delivery was 8.5 ± 0.3 hours (12). This is 
explained by the effectiveness of high dose 
regimen protocol in shortening of labor duration 
which is shown in both studies. 
        Mean time gap between oxytocin initiation 
and diagnosis of failed induction was (9:57±2:01 
hours) with a range of 6:00-14:00 hours. It was 
comparable to the Addis’ time (9:35±3:10 hours) 
(6).  
In conclusion, the rate of failed induction was 
found to be higher than most of the studies. Higher 
mean maximum doses of oxytocin were used. 
Time from start of induction with oxytocin to 
vaginal delivery was comparable to most of the 
studies with high dose oxytocin and time to 
diagnosis of failed induction was comparable to 
the study in Ethiopian. Primigravidity and having 
admission Bishop Scores of unfavorable and 
intermediate were found to be predictors for failed 
induction. Given the fact that only two non-
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modifiable risk factors for failure of induction 
with oxytocin were identified in this study, we 
recommend large scale studies to uncover other 
factors which could explain the high rate of 
induction failure. Revision of the protocol by the 
department is also recommended as duration of 
specific amount of dose and not high level of 
oxytocin would affect success. Additionally, time 
to define failed induction needs to be prolonged! 
Preparation of the cervix before commencing 
induction in primigravid women is recommended 
to improve success of induction with the current 
protocol. And, effects of various types of cervical 
ripening agents and quality of the oxytocin used 
and consistency of administration of drugs on the 
outcome of induction should also be studied. The 
fact that this is a retrospective type of data 
collection, and paucity of researches done in this 
subject in resource limited areas are the limitations 
of the study. 
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